Meridian Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-430
| Closed | -$214K | – | 115 |
|
|
2025
Q1 | $214K | Sell |
430
-12
| -3% | -$5.97K | 0.03% | 97 |
|
|
2024
Q4 | $230K | Sell |
442
-71
| -14% | -$36.9K | 0.03% | 99 |
|
|
2024
Q3 | $317K | Sell |
513
-6
| -1% | -$3.71K | 0.05% | 81 |
|
|
2024
Q2 | $287K | Buy |
519
+32
| +7% | +$17.7K | 0.05% | 85 |
|
|
2024
Q1 | $283K | Buy |
487
+37
| +8% | +$21.5K | 0.05% | 85 |
|
|
2023
Q4 | $239K | Sell |
450
-35
| -7% | -$18.6K | 0.05% | 91 |
|
|
2023
Q3 | $246K | Sell |
485
-14
| -3% | -$7.09K | 0.05% | 81 |
|
|
2023
Q2 | $260K | Sell |
499
-12
| -2% | -$6.26K | 0.05% | 78 |
|
|
2023
Q1 | $295K | Buy |
511
+64
| +14% | +$36.9K | 0.06% | 68 |
|
|
2022
Q4 | $246K | Buy |
+447
| New | +$246K | 0.06% | 74 |
|
|
2022
Q1 | – | Sell |
-317
| Closed | -$211K | – | 90 |
|
|
2021
Q4 | $211K | Buy |
+317
| New | +$211K | 0.04% | 77 |
|
|
2021
Q2 | – | Sell |
-297
| Closed | -$136K | – | 1145 |
|
|
2021
Q1 | $136K | Buy |
297
+11
| +4% | +$5.04K | 0.04% | 88 |
|
|
2020
Q4 | $133K | Buy |
286
+10
| +4% | +$4.65K | 0.05% | 81 |
|
|
2020
Q3 | $122K | Buy |
276
+1
| +0.4% | +$442 | 0.06% | 79 |
|
|
2020
Q2 | $99K | Buy |
275
+1
| +0.4% | +$360 | 0.05% | 93 |
|
|
2020
Q1 | $78K | Sell |
274
-9
| -3% | -$2.56K | 0.05% | 101 |
|
|
2019
Q4 | $92K | Buy |
+283
| New | +$92K | 0.06% | 98 |
|